QR kód

Outcomes following the use of angiotensin II in patients with postoperative vasoplegic syndrome: A case series

Catecholamine-resistant postoperative vasoplegic syndrome (PVS) lacks effective treatment modalities. Synthetic angiotensin II was recently approved for the treatment of vasodilatory shock; however, its use in PVS is not well described. We report outcomes in six patients receiving angiotensin II for...

Celý popis

Uloženo v:
Hlavní autoři: Samuel B Konkol, Matthew J Morrisette, Matthew C Hulse, Kyle B Enfield, Andrew D Mihalek
Médium: Artigo
Jazyk:Inglês
Vydáno: Wolters Kluwer Medknow Publications 2022-01-01
Edice:Annals of Cardiac Anaesthesia
Témata:
angiotensin ii
cardiac vasoplegia
postoperative vasoplegic syndrome
shock
On-line přístup:http://www.annals.in/article.asp?issn=0971-9784;year=2022;volume=25;issue=3;spage=359;epage=361;aulast=Konkol
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Podobné jednotky